Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
STEM
|
John Eugene Carrington
CEO and Director |
SELL
Payment of exercise price or tax liability
|
Direct | 68,416 Reduced 12.18% |
$738,893
$10.8 p/Share
|
Apr 06
2022 |
STEM
|
John Eugene Carrington
CEO and Director |
BUY
Exercise of conversion of derivative security
|
Direct | 133,465 Added 19.2% |
$166,831
$1.25 p/Share
|
Apr 06
2022 |
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 42,009 Reduced 79.81% |
$4,621,830
$110.02 p/Share
|
Apr 06
2022 |
HZNP
|
Paul W. Hoelscher
EVP, CFO |
SELL
Open market or private sale
|
Direct | 215,335 Reduced 99.52% |
$23,689,004
$110.01 p/Share
|
Apr 06
2022 |
HZNP
|
Paul W. Hoelscher
EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 215,335 Added 49.88% |
$4,102,132
$19.05 p/Share
|
Apr 06
2022 |
HZNP
|
Paul W. Hoelscher
EVP, CFO |
SELL
Open market or private sale
|
Indirect | 91,710 Reduced 57.9% |
$10,089,017
$110.01 p/Share
|
Apr 06
2022 |
NP
|
Michael W Rickheim
EVP, CHRO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 226 Reduced 2.11% |
$8,798
$38.93 p/Share
|
Apr 06
2022 |
PRTY
|
Clifford Sosin
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,162,500 Added 5.71% |
$3,778,125
$3.25 p/Share
|
Apr 06
2022 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Bona fide gift
|
Direct | 4,000 Reduced 0.07% |
-
|
Apr 06
2022 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 0.16% |
$1,432,440
$159.16 p/Share
|
Apr 06
2022 |
MRNA
|
Juan Andres
Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 18.07% |
$315,000
$157.5 p/Share
|
Apr 06
2022 |
MRNA
|
Juan Andres
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 15.3% |
$28,440
$14.22 p/Share
|
Apr 06
2022 |
UPST
|
Alison Nicoll
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 3.87% |
$736,200
$98.16 p/Share
|
Apr 06
2022 |
UPST
|
Alison Nicoll
General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 7,500 Added 3.72% |
$4,500
$0.6 p/Share
|
Apr 06
2022 |
PFIE
|
Patrick David Fisher
VP of Product Development |
BUY
Grant, award, or other acquisition
|
Direct | 14,341 Added 9.29% |
$18,500
$1.29 p/Share
|
Apr 06
2022 |
PFIE
|
Cameron M. Tidball
Co-CEO |
BUY
Grant, award, or other acquisition
|
Direct | 76,744 Added 13.17% |
$99,000
$1.29 p/Share
|
Apr 06
2022 |
EPSN
|
Bruce Lane Bond
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 12,825 Added 11.57% |
-
|
Apr 06
2022 |
TLMD
|
Barbara Peterson Byrne |
SELL
Sale (or disposition) back to the issuer
|
Direct | 58,387 Reduced 100.0% |
$175,161
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Thomas J. Carella |
SELL
Sale (or disposition) back to the issuer
|
Direct | 90,591 Reduced 100.0% |
$271,773
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Gyasi C. Chisley |
SELL
Sale (or disposition) back to the issuer
|
Direct | 44,150 Reduced 100.0% |
$132,450
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Christopher M. Gallagher
Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect | 401,243 Reduced 100.0% |
-
|
Apr 06
2022 |
TLMD
|
Christopher M. Gallagher
Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct | 3,316,679 Reduced 100.0% |
-
|
Apr 06
2022 |
TLMD
|
Joseph P Greskoviak |
SELL
Sale (or disposition) back to the issuer
|
Direct | 79,185 Reduced 100.0% |
$237,555
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Robert Jason Hallock
Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 15,677 Reduced 100.0% |
$47,031
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Eunice Kim
General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct | 22,168 Reduced 100.0% |
$66,504
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Amr Kronfol |
SELL
Sale (or disposition) back to the issuer
|
Direct | 101,325 Reduced 100.0% |
$303,975
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Anne Mc George |
SELL
Sale (or disposition) back to the issuer
|
Direct | 58,387 Reduced 100.0% |
$175,161
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
David Mikula
Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 496,576 Reduced 100.0% |
$1,489,728
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Steven J Shulman |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,112,291 Reduced 100.0% |
$3,336,873
$3.0 p/Share
|
Apr 06
2022 |
TLMD
|
Warburg Pincus & Co.
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 33,874,965 Reduced 100.0% |
$101,624,895
$3.0 p/Share
|
Apr 06
2022 |
ISBC
|
Michele N Siekerka
Director |
SELL
Other acquisition or disposition
|
Indirect | 22,552 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Michele N Siekerka
Director |
SELL
Other acquisition or disposition
|
Direct | 150,147 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Paul Stathoulopoulos
Director |
SELL
Other acquisition or disposition
|
Direct | 215,430 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Dennis M Bone
Director |
SELL
Other acquisition or disposition
|
Direct | 155,674 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Domenick A Cama
President and COO |
SELL
Other acquisition or disposition
|
Indirect | 135,654 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Domenick A Cama
President and COO |
SELL
Other acquisition or disposition
|
Direct | 1,196,633 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
James J. Garibaldi
Director |
SELL
Other acquisition or disposition
|
Direct | 56,980 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
James J. Garibaldi
Director |
SELL
Other acquisition or disposition
|
Indirect | 10,000 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Kevin Cummings
Chairman and CEO |
SELL
Other acquisition or disposition
|
Direct | 1,522,384 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Kevin Cummings
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 64,750 Reduced 4.08% |
$966,718
$14.93 p/Share
|
Apr 06
2022 |
ISBC
|
Kevin Cummings
Chairman and CEO |
SELL
Other acquisition or disposition
|
Indirect | 144,659 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
William V. Cosgrove
Director |
SELL
Other acquisition or disposition
|
Indirect | 11,128 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
William V. Cosgrove
Director |
SELL
Other acquisition or disposition
|
Direct | 136,752 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
John E Sr Harmon
Director |
SELL
Other acquisition or disposition
|
Direct | 1,100 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
James H Ward Iii
Director |
SELL
Other acquisition or disposition
|
Indirect | 196,565 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
James H Ward Iii
Director |
SELL
Other acquisition or disposition
|
Direct | 239,835 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Paul Kalamaras
Senior EVP |
SELL
Other acquisition or disposition
|
Direct | 261,385 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
Paul Kalamaras
Senior EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 29,229 Reduced 10.06% |
$436,389
$14.93 p/Share
|
Apr 06
2022 |
ISBC
|
Paul Kalamaras
Senior EVP |
SELL
Other acquisition or disposition
|
Indirect | 77,339 Reduced 100.0% |
-
|
Apr 06
2022 |
ISBC
|
P. Sean Burke
EVP and CFO |
SELL
Other acquisition or disposition
|
Direct | 141,130 Reduced 100.0% |
-
|
Apr 06
2022 |